Steroid-induced diabetes in rheumatologic patients

被引：1

作者：

Angelopoulos, T. P. ^{[1
]}

Tentolouris, N. K. ^{[2
]}

Bertsias, G. K. ^{[3
]}

Boumpas, D. T. ^{[1
]}

机构：

[1] Acad Athens, Inst Biomed Res, Rheumatol Clin Immunol Unit, Athens, Greece

[2] Univ Athens, Sch Med, Dept Propaedeut Med 1, Laiko Gen Hosp, GR-11527 Athens, Greece

[3] Univ Crete, Sch Med, Dept Rheumatol Clin Immunol & Allergy, Iraklion, Greece

来源：

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2014年 / 32卷 / 01期

关键词：

glucocorticoids; rheumatologic patients; hyperglycaemia; diabetes; cardiovascular risk; CEREBROVASCULAR EVENTS; ENDOTHELIAL FUNCTION; ARTHRITIS PATIENTS; RISK-FACTORS; GLUCOCORTICOIDS; PREVALENCE; MELLITUS; INSULIN; GLUCOSE; PHARMACOKINETICS;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Glucocorticoids are widely used to suppress inflammation especially in the acute phase in several inflammatory and autoimmune rheumatologic diseases. Despite their efficacy, their long-term use or at high doses is associated with numerous well-characterised side effects. Hyperglycaemia or frank diabetes is one of the most common, as its prevalence is estimated between 10-20%. Its pathophysiology is mainly due to increased insulin resistance. In this review, we provide a practical guide on how to monitor patients who are started on glucocorticoids, and how to detect and manage steroid-induced hyperglycaemia or diabetes.

引用

页码：126 / 130

页数：5

共 50 条

[1] Steroid-induced hyperglycaemia and steroid-induced diabetes in haematology ward: Quality improvement project
Raheem, A. A.
Ross, S.
Lazarus, K.
Nogueira, E.
Ahmed, G.
Hui, E.
[J]. DIABETIC MEDICINE, 2020, 37 : 66 - 66
[2] Incidence of Steroid-induced Diabetes in COVID-19 patients
Rana, Muhammad Asim
Siddiqui, Mujtaba Hasan
Raza, Sitara
Tehreem, Kinza
Mahmood, Muhammad Fahad Ullah
Javed, Muhammad
Qayyum, Mohammad Ahad
Hafeez, Muhammad Mansoor
[J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (10): : 2595 - 2596
[3] Troglitazone is an effective therapeutic agent in patients with steroid-induced diabetes
Willi, SM
Wallace, P
O'Rear, DS
Wojciechowski, B
Garvey, WT
[J]. DIABETES, 2000, 49 : A129 - A129
[4] Management of Hyperglycemia in Hospitalized Patients with Renal Insufficiency or Steroid-Induced Diabetes
David Baldwin
Jill Apel
[J]. Current Diabetes Reports, 2013, 13 : 114 - 120
[5] The novel mechanism of steroid-induced diabetes mellitus
Avinash, Holla
Sudha, Vidyasagar
Laxminarayan, Bairy
Nandakrishna, B.
Shastry, B. A.
Asha, Kamath
Hande, Manjunath
[J]. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2020, 40 (03) : 399 - 405
[6] Incidence and Risk Factors of Steroid-induced Diabetes in Patients with Respiratory Disease
Kim, Seo Yun
Yoo, Chul-Gyu
Lee, Chun Taeg
Chung, Hee Soon
Kim, Young Whan
Han, Sung Koo
Shim, Young-Soo
Yim, Jae-Joon
[J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (02) : 264 - 267
[7] Management of Hyperglycemia in Hospitalized Patients with Renal Insufficiency or Steroid-Induced Diabetes
Baldwin, David
Apel, Jill
[J]. CURRENT DIABETES REPORTS, 2013, 13 (01) : 114 - 120
[8] Steroid-induced diabetes: about 18 cases
M'zah, D.
Rahmoune, I.
El Kamrimi, H.
Meftah, A.
Elrherbi, A.
Filali, H.
Tazi, A.
Hakkou, F.
[J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 110 - 110
[9] The Unmasking of Diabetes Mellitus by Steroid-Induced Hyperglycemia
Goubeaux, Derrick L.
Lewis, Kevin
[J]. JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2015, 30 (02): : 431 - 431
[10] Control of steroid-induced diabetes with supplemental chromium
Ravina, A
Slezak, L
Mirsky, N
Anderson, RA
[J]. JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE, 1999, 12 (04): : 375 - 378

← 1 2 3 4 5 →